MBCATs AS MODIFIERS OF THE BETA-CATENIN PATHWAY AND METHODS OF USE

摘要

Human MBCAT genes are identified as modulators of the beta-catenin pathway, and thus are therapeutic targets for disorders associated with defective beta-catenin function. Methods for identifying modulators of beta-catenin, comprising screening for agents that modulate the activity of MBCAT are provided.